Science Sun Pharm released its 2024 annual performance, turning from profit to a loss of 68.8531 million yuan

According to the Zhitong Finance APP, Science Sun Pharm released its annual report for 2024, showing an operating income of 416 million yuan, a year-on-year decrease of 12.61%. The net loss attributable to shareholders of the listed company was 68.8531 million yuan. The net profit attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 11.76 million yuan. The basic loss per share was 0.14 yuan

According to the Zhitong Finance APP, Science Sun Pharm (300485.SZ) released its annual report for 2024, showing an operating income of 416 million yuan, a year-on-year decrease of 12.61%. The net loss attributable to shareholders of the listed company was 68.8531 million yuan. The net profit attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 11.76 million yuan. The basic loss per share was 0.14 yuan